Search

Your search keyword '"Iwao Kukimoto"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Iwao Kukimoto" Remove constraint Author: "Iwao Kukimoto"
115 results on '"Iwao Kukimoto"'

Search Results

1. A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan

2. Application of organoid culture from HPV18‐positive small cell carcinoma of the uterine cervix for precision medicine

Catalog

Books, media, physical & digital resources

3. Whole-genome analysis of human papillomavirus 67 isolated from Japanese women with cervical lesions

4. Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age

5. Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer

6. Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia

7. Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages

8. Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia

9. High Levels of Within-Host Variations of Human Papillomavirus 16 E1/E2 Genes in Invasive Cervical Cancer

10. Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan

11. Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program

12. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia

13. A case of primary signet-ring cell carcinoma of the cervix containing full genome of human papillomavirus 16

14. Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer

15. Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions

17. Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry.

18. Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing.

19. Folliculin Prevents Lysosomal Degradation of Human Papillomavirus To Support Infectious Cell Entry

20. Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women

22. Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia

23. Comparison of prevalence of Felis catus papillomavirus type 2 in squamous cell carcinomas in cats between Taiwan and Japan

24. Evaluation of CD4

25. Performance of Nomogram Prediction Combining MiRNAs in Cervical Mucus, HPV Genotype and Age for Cervical Cancer and its Precursor Lesions

26. Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program

27. Evaluation of CD4+ cells infiltration as a prognostic factor in cervical intraepithelial neoplasia 2.

28. Transcription Factor Homeobox D9 Drives the Malignant Phenotype of HPV18-Positive Cervical Cancer Cells via Binding to the Viral Early Promoter

29. Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates

30. IFN-γ‒Induced APOBEC3B Contributes to Merkel Cell Polyomavirus Genome Mutagenesis in Merkel Cell Carcinoma

31. Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages

32. Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine

33. Molecular epidemiology of human papillomavirus 18 infections in Japanese Women

34. Differential expression of human papilloma virus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia

35. Genome-wide association study of cervical cancer suggests a role forARRDC3gene in human papillomavirus infection

36. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1

37. The homeobox transcription factor HOXC13 upregulates human papillomavirus E1 gene expression and contributes to viral genome maintenance

38. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter

39. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex

40. [Human Papillomavirus Carcinogenesis Mediated by APOBEC Mutagenesis]

41. Comparison of methods using paraffin‐embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution

42. Comparison of prevalence of Felis catus papillomavirus type 2 in squamous cell carcinomas in cats between Taiwan and Japan.

43. Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages

44. Establishment and Molecular Phenotyping of Organoids from the Squamocolumnar Junction Region of the Uterine Cervix

45. Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia

46. Cytokine expression profiles in cervical mucus from patients with cervical cancer and its precursor lesions

47. Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome

48. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia

49. Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6

50. Hypermutation in theE2gene of human papillomavirus type 16 in cervical intraepithelial neoplasia